Novo is ramping up output to satisfy soaring demand from customers in The usa, where the drug sells for as much as $one,350 a month. It says it's going to carefully monitor prescriptions in Germany to make certain accessibility for those with weight problems, nonetheless it can't not rule out supply delays.I haven't had an appointment with a ph